Traditional MedicareCoverageMedium impact
MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing
Medicare/CMS - LCD·Infectious Disease, Internal Medicine, Family Medicine +2 more·Local Coverage Determination
Effective date
Apr 16, 2026
We identified it
Jun 17, 2026
Summary
This is a new Local Coverage Determination (LCD) for molecular syndromic panels used to identify infectious disease pathogens, effective April 16, 2026. The policy establishes coverage criteria and billing requirements for these specialized diagnostic tests under Medicare.
Action Required
By April 16, 2026: Billing team must review the full LCD L39038 policy text to identify specific coverage criteria, documentation requirements, and affected CPT codes for molecular syndromic panels for infectious disease testing. Update billing procedures and prior authorization workflows as specified in the complete policy. Ensure providers understand any new medical necessity requirements before the effective date.